544220 — Clinitech Laboratory Share Price
Last trade - 00:00- IN₹103.05m
- IN₹57.20m
- IN₹64.03m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.08 | ||
| Price to Tang. Book | 1.2 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.39 | ||
| EV to EBITDA | 4.48 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 7.3% | ||
| Return on Equity | 8.74% | ||
| Operating Margin | 9.63% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | n/a | 45.54 | 63.84 | 63.48 | 64.03 | n/a | n/a | 12.03% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +27.4 | +19.59 | -40.74 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Clinitech Laboratory Limited is engaged in the business of providing pathology and related healthcare services. It is a provider diagnostic and healthcare tests and services through a chain of diagnostic centers in and around Thane and Navi Mumbai. It conducts more than 150 tests at its centers, which are classified under various heads, such as biochemistry tests, immunology tests, hematology tests, molecular biology tests, serology tests, microbiology tests, and histopathology tests, among others. Its serology test is used to detect antibodies in the blood, which are produced by the immune system in response to infections or other foreign substances. Its microbiology test is used for identifying the causative agents of infections, determining their susceptibility to antibiotics, and monitoring treatment efficacy. It offers various test packages, including CTL Silver, CTL Gold, CTL Diamond For Him, CTL Diamond For Her, CTL Platinum, CTL Deluxe (full body), and CTL Royal (full body).
Directors
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- March 19th, 2010
- Public Since
- August 1st, 2024
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 2,282,400
- Address
- MUMBAI, 400708
- Web
- https://www.ctllab.in/
- Phone
- Contact
- Bharat Bohra
- Auditors
- M/s. KALE MALDE & CO
Similar to 544220
Aashka Hospitals
Bombay Stock Exchange
Abate As Industries
Bombay Stock Exchange
Asarfi Hospital
Bombay Stock Exchange
Aspira Pathlab & Diagnostics
Bombay Stock Exchange
Broach Lifecare Hospital
Bombay Stock Exchange
FAQ
As of Today at 19:59 UTC, shares in Clinitech Laboratory are trading at IN₹45.15. This share price information is delayed by 15 minutes.
Shares in Clinitech Laboratory last closed at IN₹45.15 and the price had moved by over the past 365 days. In terms of relative price strength the Clinitech Laboratory share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreClinitech Laboratory does not currently pay a dividend.
Clinitech Laboratory does not currently pay a dividend.
Clinitech Laboratory does not currently pay a dividend.
To buy shares in Clinitech Laboratory you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹45.15, shares in Clinitech Laboratory had a market capitalisation of IN₹103.05m.
Here are the trading details for Clinitech Laboratory:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 544220
Based on an overall assessment of its quality, value and momentum Clinitech Laboratory is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Clinitech Laboratory. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -42.94%.
As of the last closing price of IN₹45.15, shares in Clinitech Laboratory were trading -38.35% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Clinitech Laboratory PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹45.15.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Clinitech Laboratory's directors